×
After 10 years of follow-up, a study shows that taking Arimidex for 5 years is better at reducing the risk of hormone-receptor-positive breast cancer recurrence than taking tamoxifen for 5 years. These results were presented at the 2010 American Society of Clinical Oncology (ASCO) Breast Cancer Symposium.
Oct 3, 2010
People also ask
Aug 15, 2018 · Arimidex (anastrozole) and tamoxifen are used to treat breast cancer. Arimidex is used in postmenopausal women and is often given to women ...
Comparing Arimidex vs Tamoxifen ; Arimidex has an average rating of 5.8 out of 10 from a total of 80 ratings on Drugs.com. 38% of reviewers reported a positive ...
Dec 12, 2015 · The studies found that Arimidex and tamoxifen both reduced the risk of recurrence (the cancer coming back) about the same amount, but there were ...
Missing: comparison | Show results with:comparison
Sep 21, 2016 · The data from this study show that anastrozole is at least as effective as tamoxifen as first-line therapy of advanced breast cancer in ...
This study is a meta-analysis with the objective of comparing the efficacy and safety of anastrozole versus tamoxifen as adjuvant treatment for breast cancer.
Feb 10, 2016 · Previously reported results showed that anastrozole was slightly better than tamoxifen in preventing recurrence. The 10-year breast cancer–free ...
Conclusions. No clear efficacy differences were seen between the two treatments. Anastrozole offers another treatment option for postmenopausal women with ...
The trial compared the efficacy and tolerability of anastrozole 1 mg once daily with tamoxifen 20 mg once daily as first-line therapy for advanced breast cancer ...
Dec 29, 2020 · We did see differences in side effect profiles of the two medications with a higher risk for secondary cancers, including endometrial cancer, ...
Missing: comparison | Show results with:comparison